Skip Nav Destination
Issues
1 September 1998
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
AACR American Cancer Society Award Lecture
Research Articles
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
T L Vaughan; D C Farrow; P D Hansten; W H Chow; M D Gammon; H A Risch; J L Stanford; J B Schoenberg; S T Mayne; H Rotterdam; R Dubrow; H Ahsan; A B West; W J Blot; J F Fraumeni, Jr
Short Communications
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.